*Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treat... GlobeNewswire
Market data is delayed by at least 15 minutes.
    Chart Options
    Timeframe
    Frequency
    Graphical Display
    Upper Chart
    Lower Chart
    Compare to Index
    Compare to Company(s)
    Set Chart Options

    Market data provided by News provided by